Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes

M. M. J. Zanders, H. R. Haak, M. P. P. van Herk-Sukel, R. M. C. Herings, L. V. van de Poll-Franse, J. A. Johnson

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)22-29
Number of pages8
JournalDiabetes & Metabolism
Volume44
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • Cancer
  • Diabetes
  • Glucose-lowering drugs
  • Treatment changes
  • GLYCEMIC CONTROL
  • INSULIN-USE
  • RISK
  • MELLITUS
  • THERAPY
  • METAANALYSIS
  • MEDICATIONS
  • ADHERENCE
  • START

Cite this

Zanders, M. M. J., Haak, H. R., van Herk-Sukel, M. P. P., Herings, R. M. C., van de Poll-Franse, L. V., & Johnson, J. A. (2018). Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes. Diabetes & Metabolism, 44(1), 22-29. https://doi.org/10.1016/j.diabet.2017.08.004